Projects per year
Fingerprint
Dive into the research topics where Lufang Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Synergistically Target Mitochondria for Heart Failure Treatment
Zhou, L. (PI)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
07/1/23 → 06/30/27
Project: Research
-
Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
Liu, X. M. (PI), Yang, E. S. (CoPI) & Zhou, L. (CoPI)
06/10/22 → 05/31/27
Project: Research
-
Delineate the Pathophysiological Effect of Cardiomyocyte-specific Mitochondrial Stress
Zhou, L. L. (PI) & Zhou, L. (CoPI)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
07/6/21 → 06/30/26
Project: Research
-
A Novel Optogenetic Tool for Precise Mitochondrial Control
Zhou, L. (PI)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
04/1/16 → 03/31/19
Project: Research
-
Mitochondria-SR Redox Signaling and Ca2+ Handling in Healthy and Failing Hearts
Zhou, L. (PI)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
04/1/15 → 02/28/21
Project: Research
-
Advanced CD276-Targeting Dual-Payload Antibody-Drug Conjugates for Cancer Therapy
Zhou, Z., Ballard, D., Zhang, J., Du, Z., Watcharadulyarat, N., Varadkar, T., Chowdhury, S., Kambam, S. R., Hu, P., Khanal, S., Zhou, L. & Liu, X., Jan 2026, In: Cancer research communications. 6, 4, p. 898-912 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer
Zhou, Z., Ballard, D., Varadkar, T., Zhang, J., Du, Z., George, A., Krabacher, A., Yengo, R., Zhou, L. & Liu, X. “., 2025, In: Frontiers in Oncology. 15, 1663743.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer
Varadkar, T., Zhou, Z. Z., Zhang, J., Sarkar, A., Du, Z., Chowdhury, S., Lim, H., Zhou, L. & Liu, X. M., Dec 2025, In: Journal of Experimental and Clinical Cancer Research. 44, 1, 328.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Correction: Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment (Pharmaceutics, (2020), 12, 11, (1079), 10.3390/pharmaceutics12111079)
Si, Y., Guan, J. S., Xu, Y., Chen, K., Kim, S., Zhou, L., Jaskula-Sztul, R. & Liu, X. M., Oct 2025, In: Pharmaceutics. 17, 10, 1317.Research output: Contribution to journal › Comment/debate
Open Access -
Optogenetic mitochondrial preconditioning enhances cardiomyocyte survival under stress
Kim, S., Lim, H., Ernst, P., Zhu, L., Zhang, J., Xie, M., Liu, X. “. & Zhou, L., Aug 2025, In: Journal of Molecular and Cellular Cardiology. 205, p. 24-36 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations